TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effects of Inspiratory Muscle Training in Patients With Chronic Obstructive Pulmonary Disease - a Randomized Controlled Trial
Brief Summary: The additional effect of inspiratory muscle training as an adjunct to a general exercise training program in patients with COPD with inspiratory muscle weakness will be studied. The main hypothesis is that inspiratory muscle training combined with an exercise training program improves functional exercise capacity more than an exercise training program without the addition of an inspiratory muscle training program.


Options:
A: Arm Label: Standard Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Tai Chi Exercise; Type: EXPERIMENTAL; Interventions: Behavioral: Tai Chi | Arm Label: Group Walking Exercise; Type: EXPERIMENTAL; Interventions: Behavioral: Group Walking | Intervention Type: BEHAVIORAL; Name: Tai Chi; Assigned to Arm(s): Tai Chi Exercise | Intervention Type: BEHAVIORAL; Name: Group Walking; Assigned to Arm(s): Group Walking Exercise
B: Arm Label: Inspiratory Muscle Training; Type: EXPERIMENTAL; Interventions: Procedure: Inspiratory Muscle Training | Arm Label: Sham IMT; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Inspiratory Muscle Training | Intervention Type: PROCEDURE; Name: Inspiratory Muscle Training; Assigned to Arm(s): Inspiratory Muscle Training, Sham IMT
C: Arm Label: Arm A (myAIRVO2® + HOT, HOT); Type: EXPERIMENTAL; Interventions: Device: High-flow nasal cannula therapy, Device: Home oxygen therapy (HOT) | Arm Label: Arm B (HOT, myAIRVO2® + HOT); Type: EXPERIMENTAL; Interventions: Device: High-flow nasal cannula therapy, Device: Home oxygen therapy (HOT) | Intervention Type: DEVICE; Name: High-flow nasal cannula therapy; Assigned to Arm(s): Arm A (myAIRVO2® + HOT, HOT), Arm B (HOT, myAIRVO2® + HOT) | Intervention Type: DEVICE; Name: Home oxygen therapy (HOT); Assigned to Arm(s): Arm A (myAIRVO2® + HOT, HOT), Arm B (HOT, myAIRVO2® + HOT)
D: Arm Label: Telerehabilitation; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise training at home, Behavioral: Telemonitoring and education/self-management | Arm Label: Unsupervised exercise training at home; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise training at home | Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Exercise training at home; Assigned to Arm(s): Telerehabilitation, Unsupervised exercise training at home | Intervention Type: BEHAVIORAL; Name: Telemonitoring and education/self-management; Assigned to Arm(s): Telerehabilitation

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effects of Inspiratory Muscle Training in Patients With Chronic Obstructive Pulmonary Disease - a Randomized Controlled Trial
Brief Summary: The additional effect of inspiratory muscle training as an adjunct to a general exercise training program in patients with COPD with inspiratory muscle weakness will be studied. The main hypothesis is that inspiratory muscle training combined with an exercise training program improves functional exercise capacity more than an exercise training program without the addition of an inspiratory muscle training program.


Options:
A: Arm Label: Inspiratory muscle training; Type: EXPERIMENTAL; Interventions: Procedure: Inspiratory muscle training | Intervention Type: PROCEDURE; Name: Inspiratory muscle training; Assigned to Arm(s): Inspiratory muscle training
B: Arm Label: Inspiratory muscle training; Type: EXPERIMENTAL; Interventions: Other: Inspiratory Muscle training | Arm Label: Declining Inspiratory muscle training; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Inspiratory Muscle training; Assigned to Arm(s): Inspiratory muscle training
C: Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: inspiratory pressure training group; Type: EXPERIMENTAL; Interventions: Device: inspiratory pressure training group | Arm Label: mixed training group; Type: EXPERIMENTAL; Interventions: Device: mixed training group | Intervention Type: DEVICE; Name: inspiratory pressure training group; Assigned to Arm(s): inspiratory pressure training group | Intervention Type: DEVICE; Name: mixed training group; Assigned to Arm(s): mixed training group
D: Arm Label: Inspiratory Muscle Training; Type: EXPERIMENTAL; Interventions: Procedure: Inspiratory Muscle Training | Arm Label: Sham IMT; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Inspiratory Muscle Training | Intervention Type: PROCEDURE; Name: Inspiratory Muscle Training; Assigned to Arm(s): Inspiratory Muscle Training, Sham IMT

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of the Efficacy of Camouflage Syringe in Reducing Dental Anxiety and Fear in Children
Brief Summary: Dental fear and anxiety in children constitue a crucial challenge to dental care delivery as well as future behavior related to dental problems in children. A common cause of such anxiety and fear is the procedural intervention that uses needles and syringes since a visual impact due to the needle acts as a deterrent to the child's cooperation during dental procedures. We therefore improvised the syringe such that it will camouflage the needle. We hypothesized that the use of this needle will alleviate the child's anxiety and therefore will demonstrate improved outcomes related to pain, fear and anxiety. This study is a group randomized trial to test the efficacy of the camouflage syringe as compared to the conventional syringe in children.


Options:
A: Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: info group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: info | Arm Label: smartphone group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: smartphone | Arm Label: smartphone and info group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: info, Behavioral: smartphone | Intervention Type: BEHAVIORAL; Name: info; Assigned to Arm(s): info group, smartphone and info group | Intervention Type: BEHAVIORAL; Name: smartphone; Assigned to Arm(s): smartphone and info group, smartphone group
B: Arm Label: Standard Care; Type: OTHER; Interventions: Other: vapocoolant | Arm Label: Buzzy; Type: EXPERIMENTAL; Interventions: Device: Buzzy | Intervention Type: DEVICE; Name: Buzzy; Assigned to Arm(s): Buzzy | Intervention Type: OTHER; Name: vapocoolant; Assigned to Arm(s): Standard Care
C: Arm Label: Conventional syringe; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Camouflage syringe; Type: EXPERIMENTAL; Interventions: Procedure: Camouflage syringe | Intervention Type: PROCEDURE; Name: Camouflage syringe; Assigned to Arm(s): Camouflage syringe
D: Arm Label: music; Type: EXPERIMENTAL; Interventions: Behavioral: music | Arm Label: Standard care; Type: OTHER; Interventions: Behavioral: music | Intervention Type: BEHAVIORAL; Name: music; Assigned to Arm(s): Standard care, music

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase III Single-blind, Randomised Placebo Controlled Trial of Long Term Therapy in Patients With Stable COPD Using Moxifloxacin, Azithromycin and Doxycycline: a Bayesian Decision Analysis, Including Other Criteria, Will be Used to Distinguish the Optimal Antibiotic Treatment
Brief Summary: Chronic Obstructive Pulmonary Disease (COPD) is the cause of considerable deaths, and exacerbations (flare up of symptoms) are a major cause of hospital admission in the UK. Bacterial infections play an important role in the development of COPD, however, there is little information available about the use of long term antibiotics in the treatment of this disease. Therefore the purpose of this study is to identify the best antibiotic regime for treating patients with COPD who have persistent bacterial infection in their lung. We will test a variety of approaches including both older and newer regimes prescribed either on a daily basis at a lower dose or in "pulsed" courses (for example, every other day or five days every month). The three antibiotics tested in this study are: moxifloxacin, azithromycin and doxycycline. This is a 13 weeks study conducted at the Royal Free Hospital, London. It is expected that approximately 200 patients will be selected for this study. The information we get from this study may help us to treat future patients with COPD better.


Options:
A: Arm Label: Moxifloxacin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Moxifloxacin | Arm Label: Azithromycin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Azithromycin | Arm Label: Doxycycline; Type: ACTIVE_COMPARATOR; Interventions: Drug: Doxycycline | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Moxifloxacin; Assigned to Arm(s): Moxifloxacin | Intervention Type: DRUG; Name: Azithromycin; Assigned to Arm(s): Azithromycin | Intervention Type: DRUG; Name: Doxycycline; Assigned to Arm(s): Doxycycline | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Azithromycin, 250 mg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Macrolide Antibiotic (Azithromycin) | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Macrolide Antibiotic (Azithromycin); Assigned to Arm(s): Azithromycin, 250 mg | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Azithromycin; Type: EXPERIMENTAL; Interventions: Drug: Azithromycin | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Azithromycin; Assigned to Arm(s): Azithromycin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Intervention Type: DRUG; Name: tiotropium; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase III Single-blind, Randomised Placebo Controlled Trial of Long Term Therapy in Patients With Stable COPD Using Moxifloxacin, Azithromycin and Doxycycline: a Bayesian Decision Analysis, Including Other Criteria, Will be Used to Distinguish the Optimal Antibiotic Treatment
Brief Summary: Chronic Obstructive Pulmonary Disease (COPD) is the cause of considerable deaths, and exacerbations (flare up of symptoms) are a major cause of hospital admission in the UK. Bacterial infections play an important role in the development of COPD, however, there is little information available about the use of long term antibiotics in the treatment of this disease. Therefore the purpose of this study is to identify the best antibiotic regime for treating patients with COPD who have persistent bacterial infection in their lung. We will test a variety of approaches including both older and newer regimes prescribed either on a daily basis at a lower dose or in "pulsed" courses (for example, every other day or five days every month). The three antibiotics tested in this study are: moxifloxacin, azithromycin and doxycycline. This is a 13 weeks study conducted at the Royal Free Hospital, London. It is expected that approximately 200 patients will be selected for this study. The information we get from this study may help us to treat future patients with COPD better.


Options:
A: Arm Label: Erythromycin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Erythromycin | Arm Label: Placebo Group endoscopic therapy; Type: NO_INTERVENTION; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Erythromycin; Assigned to Arm(s): Erythromycin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo Group endoscopic therapy
B: Arm Label: Moxifloxacin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Moxifloxacin | Arm Label: Azithromycin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Azithromycin | Arm Label: Doxycycline; Type: ACTIVE_COMPARATOR; Interventions: Drug: Doxycycline | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Moxifloxacin; Assigned to Arm(s): Moxifloxacin | Intervention Type: DRUG; Name: Azithromycin; Assigned to Arm(s): Azithromycin | Intervention Type: DRUG; Name: Doxycycline; Assigned to Arm(s): Doxycycline | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Azithromycin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Azithromycin | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Azithromycin; Assigned to Arm(s): Azithromycin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Biannual mass oral azithromycin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Azithromycin | Arm Label: Biannual mass oral placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Azithromycin; Assigned to Arm(s): Biannual mass oral azithromycin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Biannual mass oral placebo

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Phase 3 Study of Physical Exercise and Respiratory Training as Supportive Treatments for Patients With Severe Chronic Pulmonary Hypertension
Brief Summary: Background

-Pulmonary hypertension (PH) is associated with restricted physical capacity, limited quality of life, and a poor prognosis because of right heart failure. The present study is the first prospective randomized study to evaluate the effects of exercise and respiratory training in patients with severe symptomatic PH.

Methods

-Patients with PH on stable disease-targeted medication will be randomly assigned to a control and a primary training group. Medication will remain unchanged during the study period. Primary end points will be the changes from baseline to week 15 in the distance walked in 6 minutes and in scores of the Short Form Health Survey quality-of-life questionnaire. Changes in WHO functional class, Borg scale, and parameters of echocardiography and gas exchange also will be assessed.

Prospects

-We hope this study will indicate that respiratory and physical training are a promising adjunct to medical treatment in severe PH.


Options:
A: Arm Label: Training group (A); Type: EXPERIMENTAL; Interventions: Other: Moderate intensity aerobic training | Arm Label: control group (B); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Moderate intensity aerobic training; Assigned to Arm(s): Training group (A)
B: Arm Label: Training Group; Type: ACTIVE_COMPARATOR; Interventions: Other: Upper extremity aerobic exercise training | Arm Label: Control Group; Type: SHAM_COMPARATOR; Interventions: Other: Alternative upper extremity exercises | Intervention Type: OTHER; Name: Upper extremity aerobic exercise training; Assigned to Arm(s): Training Group | Intervention Type: OTHER; Name: Alternative upper extremity exercises; Assigned to Arm(s): Control Group
C: Arm Label: exercise training group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: exercise training | Arm Label: Control group without exercise training; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: exercise training; Assigned to Arm(s): exercise training group
D: Arm Label: Exercise and Respiratory Training; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Exercise and Respiratory Training | Intervention Type: BEHAVIORAL; Name: Exercise and Respiratory Training; Assigned to Arm(s): Exercise and Respiratory Training

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Phase 3 Study of Physical Exercise and Respiratory Training as Supportive Treatments for Patients With Severe Chronic Pulmonary Hypertension
Brief Summary: Background

-Pulmonary hypertension (PH) is associated with restricted physical capacity, limited quality of life, and a poor prognosis because of right heart failure. The present study is the first prospective randomized study to evaluate the effects of exercise and respiratory training in patients with severe symptomatic PH.

Methods

-Patients with PH on stable disease-targeted medication will be randomly assigned to a control and a primary training group. Medication will remain unchanged during the study period. Primary end points will be the changes from baseline to week 15 in the distance walked in 6 minutes and in scores of the Short Form Health Survey quality-of-life questionnaire. Changes in WHO functional class, Borg scale, and parameters of echocardiography and gas exchange also will be assessed.

Prospects

-We hope this study will indicate that respiratory and physical training are a promising adjunct to medical treatment in severe PH.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: Aerobic exercise | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Other: Aerobic exercise | Intervention Type: OTHER; Name: Aerobic exercise; Assigned to Arm(s): 1, 2
B: Arm Label: Exercise and Respiratory Training; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Exercise and Respiratory Training | Intervention Type: BEHAVIORAL; Name: Exercise and Respiratory Training; Assigned to Arm(s): Exercise and Respiratory Training
C: Arm Label: exercise training group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: exercise training | Arm Label: Control group without exercise training; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: exercise training; Assigned to Arm(s): exercise training group
D: N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Patient Education After Lung Transplantation Via Tablet Computers Versus Conventional Education - a Randomized Open Controlled Trial
Brief Summary: Experimental intervention:

Patient education after lung transplantation via Tablet computers. An electronic patient questionnaire via tablet computer will be collected in addition.

Control intervention:

Conventional Patient education by health care professionals. A paper-based patient questionnaire will be provided.


Options:
A: Arm Label: Tacrolimus twice-daily; Type: ACTIVE_COMPARATOR; Interventions: Drug: Tacrolimus twice daily | Arm Label: Envarsus XR; Type: ACTIVE_COMPARATOR; Interventions: Drug: Envarsus XR | Intervention Type: DRUG; Name: Envarsus XR; Assigned to Arm(s): Envarsus XR | Intervention Type: DRUG; Name: Tacrolimus twice daily; Assigned to Arm(s): Tacrolimus twice-daily
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: behavioral adaptation and symptom management | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: behavioral adaptation and symptom management; Assigned to Arm(s): 1
C: Arm Label: Conventional Patient education; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Patient education | Arm Label: Patient education via Tablet computer; Type: EXPERIMENTAL; Interventions: Behavioral: Patient education | Intervention Type: BEHAVIORAL; Name: Patient education; Assigned to Arm(s): Conventional Patient education, Patient education via Tablet computer
D: Arm Label: Teen Pocket PATH® Mobile Application; Type: EXPERIMENTAL; Interventions: Other: Teen Pocket PATH® Mobile Application | Arm Label: Control Group: Standard of Care; Type: OTHER; Interventions: Other: Control Group: Standard of Care | Intervention Type: OTHER; Name: Teen Pocket PATH® Mobile Application; Assigned to Arm(s): Teen Pocket PATH® Mobile Application | Intervention Type: OTHER; Name: Control Group: Standard of Care; Assigned to Arm(s): Control Group: Standard of Care

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: An Interdisciplinary Knowledge Translation Intervention in Long-term Care: The Vitamin D and Osteoporosis Study (ViDOS) Pilot Cluster Randomized Controlled Trial
Brief Summary: The research question is, does a multifaceted, multidisciplinary intervention including small groups, chart audits and point of care tools, increase the number of people receiving optimal vitamin D therapy in the long term care (LTC) setting? Secondary outcomes include the number of falls and fractures experienced by the residents in each LTC home and the number of residents receiving appropriate bisphosphonate therapy.


Options:
A: Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: 8-week aerobic and strength training program | Arm Label: 1; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: 8-week aerobic and strength training program; Assigned to Arm(s): 2
B: Arm Label: LTC Osteoporosis Toolkit Only; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Educ sessions & LTC Osteoporosis toolkit; Type: ACTIVE_COMPARATOR; Interventions: Other: Educ sessions & LTC Osteoporosis toolkit | Intervention Type: OTHER; Name: Educ sessions & LTC Osteoporosis toolkit; Assigned to Arm(s): Educ sessions & LTC Osteoporosis toolkit
C: Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Interpersonal Interaction; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Interpersonal Interaction | Arm Label: Walking Program; Type: EXPERIMENTAL; Interventions: Behavioral: Walking Program | Intervention Type: BEHAVIORAL; Name: Interpersonal Interaction; Assigned to Arm(s): Interpersonal Interaction | Intervention Type: BEHAVIORAL; Name: Walking Program; Assigned to Arm(s): Walking Program
D: Arm Label: Intervention exercise; Type: EXPERIMENTAL; Interventions: Other: Intervention exercise | Arm Label: Sham exercise; Type: SHAM_COMPARATOR; Interventions: Other: Sham Exercise | Intervention Type: OTHER; Name: Intervention exercise; Assigned to Arm(s): Intervention exercise | Intervention Type: OTHER; Name: Sham Exercise; Assigned to Arm(s): Sham exercise

Answer: B